Tatsuya Fukuda, from the Tokyo Medical and Dental University, and colleagues enrolled 682 patients with type 2 diabetes and used dual bioelectrical impedance analyzer (BIA) to assess VFA and SFA. The authors divided the patients into groups according to quartiles of V/S ratio. The researchers found that 21 of the patients reached the study end point of first occurrence...